12 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.
Momenta Pharmaceuticals
A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.
The University Of Queensland
Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.
Progen Pharmaceuticals
Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.
Progen Pharmaceuticals
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway.
University Of California
Validation of molecular docking calculations involving FGF-1 and FGF-2.
Progen Industries
Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).
Progen Industries
Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.
Progen Industries
Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library.
University College Dublin